Approvals

  1. Biosimilars

    The FDA has approved the first biosimilar for the treatment of certain breast and stomach cancers.
    Industry news

    Read more »
  2. Lung cancer

    A phase 3 study on lung cancer showed that Imfinzi (durvalumab) as a consolidation therapy reduced the risk of the disease progressing by 48 percent.
    Industry news

    Read more »
  3. HIV/AIDS

    FDA approves Juluca (dolutegravir and rilpivirine) for the maintenance treatment of certain patients with HIV-1 infection.
    Industry news

    Read more »
  4. A new medicine for Alzheimer's disease?

    Introducing a breakthrough known as 'CT1812'

    alzheimer disease

    Read more »
  5. Defining ocrelizumab's role within the MS treatment landscape

    Ocrevus (ocrelizumab) was approved in the US by the FDA in March 2017 for the treatment of adults with relapsing or primary progressive forms of MS, based on three clinical trials.

    ocrelizumab MS treatment

    Read more »
  6. Edaravone availability in the US - one month to go

    As we await the arrival of edaravone to US pharmacies, patients can access edaravone now through TheSocialMedwork.edaravone best price

    Read more »
  7. Accessing edaravone in your country - the new FDA approved drug for ALS

    What are the results from the clinical studies that led to the approval of edaravone, and how can patients access it in their country?

    edaravone FDA ALS

    Read more »
  8. Radicava/Radicut (edaravone) for ALS

    For the first time in 22 years, the US Food and Drug Administration (FDA) has approved a drug to treat patients with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease; a motor neuron disease characterised by muscular atrophy and weakness.
    Radicava Radicut edaravone ALS

    Read more »
  9. Nivolumab Dominates the News

    Promising Results from Multiple Studies

    nivolumab news

    Read more »
  10. Daratumumab approved as multiple myeloma treatment

    The FDA approval of a promising new drug is offering new hope to multiple myeloma patients who have already been through various treatments. 

    Daratumumab multiple myeloma treatment

    Read more »
  11. Alectinib approved for the treatment of ALK-positive NSCLC

    A new treatment that targets a specific type of lung cancer has received FDA approval. 

    Alectinib treatment ALK-positive NSCLC

    Read more »
  12. Edaravone approved in Japan for the treatment of ALS

    The Pharmaceutical and Medical Device Agency (PMDA), has granted marketing approval for the use of Edaravone for the treatment of ALS in Japan.

    Man in a wheelchair

    Read more »
Page